Provided by Tiger Trade Technology Pte. Ltd.

ACADIA Pharmaceuticals

30.60
+0.94623.19%
Volume:748.02K
Turnover:22.76M
Market Cap:5.27B
PE:13.94
High:30.76
Open:29.99
Low:29.85
Close:29.65
52wk High:30.96
52wk Low:19.69
Shares:172.31M
Float Shares:128.72M
Volume Ratio:0.60
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.20
EPS(LYR):2.30
ROE:35.74%
ROA:3.64%
PB:4.03
PE(LYR):13.30

Loading ...

Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2022

Major Issues Report

8-K - Current report
Jun 10, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2022

Major Issues Report

8-K - Current report
Apr 08, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2021

Major Issues Report

8-K - Current report
Dec 14, 2021

Major Issues Report

8-K - Current report
Nov 23, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 05, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 02, 2021

Major Issues Report

ACADIA PHARMACEUTICALS INC
Sep 02, 2021

Major Issues Report

8-K - Current report